House Bill 4372 has been introduced in the House of Delegates requiring the Board of Pharmacy to review, investigate and make appropriate referrals of reports of suspicious orders of controlled substances.
It calls for the Board to investigate suspicious orders by controlled substances registrants and to conduct hearings on the denial, suspension or revocation of registration.
The proposed legislation directs the Board to maintain a log of reports of suspicious orders, and have the Attorney General review all suspicious orders. The Attorney General is to refer reports of suspicious orders to a law-enforcement agency with jurisdiction over the registrant and to the United States Drug Enforcement Agency.
If the report describes or indicates a suspicious order or orders that appear to have been perpetrated by a pharmacist or pharmacy technician, then the Attorney General shall notify the Board and the Board is to treat the report as a complaint of unprofessional conduct and pursue investigation of alleged conduct. The Attorney General is to take similar action when a suspicious order appears to have been perpetrated by a medical professional.
